Life Sciences
Biology, Not AI, Is Still the Bigger Organizational Risk — But 2026 Policy Treats Them as One Problem
In 2026, US policy began treating artificial intelligence and biological risks as a single, converging problem, establishing new regulations for dangerous gain-of-function research and AI monitoring in life sciences. While AI can accelerate biological threats, the article emphasizes that the physical accessibility of lab tools remains a more immediate organizational risk.
Jina Park·June 20, 2026
